Henrik Gregersen

3.3k total citations
70 papers, 1.7k citations indexed

About

Henrik Gregersen is a scholar working on Hematology, Oncology and Molecular Biology. According to data from OpenAlex, Henrik Gregersen has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Hematology, 25 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Henrik Gregersen's work include Multiple Myeloma Research and Treatments (41 papers), Cancer Treatment and Pharmacology (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Henrik Gregersen is often cited by papers focused on Multiple Myeloma Research and Treatments (41 papers), Cancer Treatment and Pharmacology (11 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Henrik Gregersen collaborates with scholars based in Denmark, Sweden and Norway. Henrik Gregersen's co-authors include Henrik Toft Sørensen, Niels Abildgaard, Annette Juul Vangsted, Henrik Hjalgrim, Ellen T. Chang, Johan Askling, Christer Sundström, Bengt Glimelius, Hans‐Olov Adami and Anna Porwit‐MacDonald and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Henrik Gregersen

65 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrik Gregersen Denmark 23 727 499 395 385 270 70 1.7k
Lawrence S. Lessin United States 25 421 0.6× 305 0.6× 630 1.6× 458 1.2× 192 0.7× 61 2.0k
Dolors Tàssies Spain 30 842 1.2× 256 0.5× 295 0.7× 284 0.7× 346 1.3× 117 3.0k
Jolanta Kowalewska United States 21 240 0.3× 702 1.4× 326 0.8× 213 0.6× 200 0.7× 49 2.4k
Christen Lykkegaard Andersen Denmark 18 323 0.4× 273 0.5× 230 0.6× 364 0.9× 102 0.4× 84 1.1k
James D. Hoyer United States 29 1.3k 1.7× 803 1.6× 471 1.2× 1.2k 3.1× 634 2.3× 121 2.8k
Sonia Pasquali Italy 26 425 0.6× 713 1.4× 146 0.4× 342 0.9× 450 1.7× 48 2.7k
Attilio Guarini Italy 25 533 0.7× 558 1.1× 616 1.6× 433 1.1× 458 1.7× 112 2.1k
José Ramón González‐Porras Spain 25 1.1k 1.5× 231 0.5× 179 0.5× 280 0.7× 135 0.5× 102 1.8k
Philippe Vanhille France 24 304 0.4× 565 1.1× 126 0.3× 301 0.8× 280 1.0× 52 2.4k
Rajen Mody United States 24 264 0.4× 540 1.1× 582 1.5× 295 0.8× 133 0.5× 99 2.1k

Countries citing papers authored by Henrik Gregersen

Since Specialization
Citations

This map shows the geographic impact of Henrik Gregersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrik Gregersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrik Gregersen more than expected).

Fields of papers citing papers by Henrik Gregersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrik Gregersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrik Gregersen. The network helps show where Henrik Gregersen may publish in the future.

Co-authorship network of co-authors of Henrik Gregersen

This figure shows the co-authorship network connecting the top 25 collaborators of Henrik Gregersen. A scholar is included among the top collaborators of Henrik Gregersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrik Gregersen. Henrik Gregersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jakobsen, Lasse, Martin Bøgsted, Henrik Gregersen, et al.. (2024). Socioeconomic Status and Overall Survival Among Patients With Hematological Malignant Neoplasms. JAMA Network Open. 7(3). e241112–e241112. 8 indexed citations
2.
Brøndum, Rasmus Froberg, et al.. (2024). A systematic literature review on clonal evolution events preceding relapse in multiple myeloma. Critical Reviews in Oncology/Hematology. 205. 104560–104560.
3.
Bøgsted, Martin, Henrik Gregersen, Robert Schou Pedersen, et al.. (2022). Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation. European Journal Of Haematology. 110(3). 289–295. 2 indexed citations
4.
Gregersen, Henrik, Tobias Wirenfeldt Klausen, Birgitte Preiss, et al.. (2021). Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients. Hematological Oncology. 39(4). 521–528. 2 indexed citations
5.
Blimark, Cecilie, Annette Juul Vangsted, Tobias Wirenfeldt Klausen, et al.. (2021). Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries. European Journal Of Haematology. 108(2). 99–108. 11 indexed citations
6.
Kristensen, Søren Risom, et al.. (2021). Prothrombotic abnormalities in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. Thrombosis Research. 202. 108–118. 14 indexed citations
7.
Christensen, Peter, et al.. (2021). Anti-Tr/DNER antibody paraneoplastic cerebellar degeneration preceding a very late relapse of Hodgkin Lymphoma after 12 years. SHILAP Revista de lepidopterología. 8(1). 14–14. 6 indexed citations
8.
9.
Klausen, Tobias Wirenfeldt, Henrik Gregersen, Niels Abildgaard, et al.. (2018). The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials. Leukemia. 33(2). 546–549. 31 indexed citations
10.
11.
Vangsted, Annette Juul, Tobias Wirenfeldt Klausen, Niels Frost Andersen, et al.. (2010). Improved survival of multiple myeloma patients with late relapse after high‐dose treatment and stem cell support, a population‐based study of 348 patients in Denmark in 1994–2004*. European Journal Of Haematology. 85(3). 209–216. 14 indexed citations
12.
Vangsted, Annette Juul, Karen Søeby, Tobias Wirenfeldt Klausen, et al.. (2010). No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma. BMC Cancer. 10(1). 404–404. 24 indexed citations
13.
Sangild, Per Torp, et al.. (2009). The preterm piglet – a model in the study of oesophageal development in preterm neonates. Acta Paediatrica. 99(2). 201–208. 18 indexed citations
14.
Gregersen, Henrik, M. A. Kwiatek, Werner Schwizer, & Radu Țuțuian. (2007). Contribution of sensitivity, volume and tone to visceral perception in the upper gastrointestinal tract in man: emphasis on testing. Neurogastroenterology & Motility. 19(s1). 47–61. 15 indexed citations
15.
Munk, Estrid Muff, Asbjørn Mohr Drewes, Anders Gorst‐Rasmussen, et al.. (2007). Risk of peptic ulcer, oesophagitis, pancreatitis or gallstone in patients with unexplained chest/epigastric pain and normal upper endoscopy: a 10‐year Danish cohort study. Alimentary Pharmacology & Therapeutics. 25(10). 1203–1210. 4 indexed citations
16.
Gregersen, Henrik, et al.. (2006). Fracture risk in patients with monoclonal gammopathy of undetermined significance. British Journal of Haematology. 135(1). 62–67. 36 indexed citations
17.
Smedby, Karin E., Henrik Hjalgrim, Johan Askling, et al.. (2006). Autoimmune and Chronic Inflammatory Disorders and Risk of Non-Hodgkin Lymphoma by Subtype. JNCI Journal of the National Cancer Institute. 98(1). 51–60. 306 indexed citations
18.
Nørgaard, Mette, Mette Vinther Skriver, Henrik Gregersen, et al.. (2005). The data quality of haematological malignancy ICD-10 diagnoses in a population-based Hospital Discharge Registry. European Journal of Cancer Prevention. 14(3). 201–206. 57 indexed citations
19.
Gregersen, Henrik, et al.. (2001). Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance. British Journal of Haematology. 112(2). 353–357. 44 indexed citations
20.
Gregersen, Henrik, et al.. (2000). Cancer risk in patients with monoclonal gammopathy of undetermined significance. American Journal of Hematology. 63(1). 1–6. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lawrence S. Lessin Breakdown of academic impact, for papers by Dolors Tàssies Breakdown of academic impact, for papers by Jolanta Kowalewska Breakdown of academic impact, for papers by Christen Lykkegaard Andersen Breakdown of academic impact, for papers by James D. Hoyer Breakdown of academic impact, for papers by Sonia Pasquali Breakdown of academic impact, for papers by Attilio Guarini Breakdown of academic impact, for papers by José Ramón González‐Porras Breakdown of academic impact, for papers by Philippe Vanhille Breakdown of academic impact, for papers by Rajen Mody
Rankless by CCL
2026